Sertraline and Taletrectinib: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Sertraline
No brand names on recordTaletrectinib
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
Both of these medicines can affect your heart's rhythm. Sertraline is a common antidepressant, and taletrectinib (Ibtrozi) is a cancer medicine. Each one can slightly stretch out the time your heart takes to reset between beats. This is called QT prolongation. When you take both together, that effect can add up, which in rare cases could lead to a dangerous irregular heartbeat.
The good news is this is a known, manageable concern. Your care team can keep an eye on your heart with ECGs, check your blood minerals (electrolytes), and adjust things if needed. Please don't stop either medicine on your own. Just talk with your doctor or pharmacist so they can watch you closely.
Interaction: Additive QTc prolongation from concurrent sertraline (a QT-prolonging SSRI) and taletrectinib, increasing risk of ventricular tachyarrhythmias including torsades de pointes.
- Mechanism: Additive pharmacodynamic effect on cardiac repolarization (neither drug is a prodrug relevant here).
- Direction/magnitude: Increased QTc; magnitude not quantified.
- Evidence: Theoretical; severity rated major.
- Management: Avoid combination if possible. If unavoidable, obtain baseline and periodic ECGs and electrolytes; correct hypokalemia/hypomagnesemia. Withhold taletrectinib if QTc greater than 500 msec or change from baseline greater than 60 msec, then resume at same/reduced dose or discontinue per severity. Intensify monitoring with additional QT risk factors.
What happens
Increased risk of QT interval prolongation and torsade de pointes
Interaction Deep Dive
Do not administer taletrectinib alongside other agents recognized as having the capacity to lengthen the QTc interval, since doing so may heighten the likelihood of QTc interval prolongation, a condition that can raise the risk of ventricular tachyarrhythmias (for instance, torsades de pointes) or sudden death. When such combined use is unavoidable, modify how often monitoring is performed according to the recommendations. Hold taletrectinib when the QTc interval exceeds 500 msec or when a shift from baseline greater than 60 msec produces QTc interval prolongation. Obtain ECGs and check electrolytes before giving taletrectinib, and thereafter at intervals as clinically warranted throughout treatment. Base the monitoring frequency on risk factors, including recognized long QT syndromes, clinically meaningful bradyarrhythmias, severe or poorly controlled heart failure, and coadministered drugs linked to QTc interval prolongation. Give taletrectinib on an empty stomach. Depending on severity, withhold taletrectinib and then restart it at the same or a lowered dose, or discontinue it permanently1.
Why it happens (mechanism)
Additive QT interval prolongation
How to manage this interaction
Keep taking both medicines exactly as prescribed unless your care team tells you otherwise. Here is what your team typically does with this combination:
- Try to avoid using them together when a suitable alternative exists.
- If they are used together, check an ECG and blood electrolytes before starting and periodically during treatment.
- Correct any low potassium or magnesium.
- Watch more closely if you have other heart-rhythm risk factors.
- Adjust or pause the taletrectinib dose if your ECG shows significant changes.
Tell your pharmacist or doctor about all your medicines, and report fainting, dizziness, or a pounding or irregular heartbeat right away.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) Within the combined safety population, among the 351 patients who had at least one post baseline ECG evaluation, 13% showed a rise in QTcF (QT interval corrected using the Fridericia formula) exceeding 60 msec relative to baseline following taletrectinib administration, and 2.6% had an increase in QTcF to more than 500 msec. In total, 3.4% of patients experienced Grade more than and equal to 3 QTc interval prolongation. The median interval from the initial taletrectinib dose to the emergence of ECG QT prolongation was 22 days (range: 1 day to 38.7 months). QTc prolongation resulted in dose interruption and dose reduction, each occurring in 2.8% of patients receiving taletrectinib 1.
Common questions
Can I take Sertraline and Taletrectinib together?
Taking sertraline with taletrectinib can add up to prolong your heart's QT interval, so your care team should monitor your ECG and electrolytes; keep taking both as prescribed and report any fainting or irregular heartbeat. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Sertraline and Taletrectinib interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Sertraline and Taletrectinib interaction managed?
Keep taking both medicines exactly as prescribed unless your care team tells you otherwise. Here is what your team typically does with this combination: Try to avoid using them together when a suitable alternative exists. If they are used together, check an ECG and blood electrolytes before starting and periodically during treatment. Correct any low potassium or magnesium. Watch more closely if yo… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
From our Q&A
Real reader questions about these medications, each personally answered by our pharmacist:
Questions for your pharmacist
- Does my dose of Sertraline or Taletrectinib need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: IBTROZI(TM) oral capsules, taletrectinib oral capsules. Nuvation Bio Inc. (per Manufacturer), Burlington, MA, 2025. DailyMed
Keep reading about Sertraline
Keep reading about Taletrectinib
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist